SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-20-078399
Filing Date
2020-03-19
Accepted
2020-03-19 09:05:39
Documents
14
Effectiveness Date
2020-03-19

Document Format Files

Seq Description Document Type Size
1 DEFM14A d867472ddefm14a.htm DEFM14A 3172493
2 GRAPHIC g810736g04v17.jpg GRAPHIC 42801
3 GRAPHIC g810736g06z11.jpg GRAPHIC 28543
4 GRAPHIC g810736g07m12.jpg GRAPHIC 30329
5 GRAPHIC g810736g21x30.jpg GRAPHIC 54004
6 GRAPHIC g810736g59u12.jpg GRAPHIC 24774
7 GRAPHIC g867472g01w28.jpg GRAPHIC 48985
8 GRAPHIC g867472g02s37.jpg GRAPHIC 39416
9 GRAPHIC g867472g1109091302552.jpg GRAPHIC 731
10 GRAPHIC g867472g1109091305272.jpg GRAPHIC 1596
11 GRAPHIC g867472g18m74.jpg GRAPHIC 1355
12 GRAPHIC g867472g21x30.jpg GRAPHIC 54004
13 GRAPHIC g867472g65y74.jpg GRAPHIC 10299
14 GRAPHIC g867472g82w04.jpg GRAPHIC 49386
  Complete submission text file 0001193125-20-078399.txt   3706839
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-23143 | Film No.: 20726605
SIC: 2834 Pharmaceutical Preparations